Having shown that VPA increases killing, replication, and GM-CSF production upon HSVGM-CSF treatment of human melanoma cells, we next tested the effects of VPA on HSVGM-CSF-induced innate anti-tumor immunity. The gene discussed is CSF2; the disease is neoplasm.